|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.340 EUR | -0.85% |
|
-4.88% | -7.14% |
| Jan. 20 | BRAIN Biotech AG, 2025 Earnings Call, Jan 14, 2026 | |
| Jan. 14 | BRAIN Biotech AG Provides Revenue Guidance for the Year 2025/2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | €5.24 | +122.03% | 5 | ||||||
| €27.47 | +283.64% | 6 | ||||||
| - | - | €5 | +71.23% | 2 | ||||
| - | - | - | €8 | -8.57% | 1 | |||
| Average | 11.43 | +117.08% | 4 | ||||||
| Weighted average by Cap. | 16.4 | +166.66% | 4 |
- Stock Market
- Equities
- BNN Stock
- Sector BRAIN Biotech AG
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
